StockWatch
·
Pharmaceuticals
Board Meeting30 Jul 2026, 05:50 pm

Colinz Laboratories Approves Un-Audited Q1 FY27 Results

AI Summary

Colinz Laboratories Ltd's Board of Directors convened on July 31, 2026, to approve the Un-Audited Financial Results for the quarter ended June 30, 2026. The results underwent a limited review by the statutory auditors. The Board also approved the Directors' Report, Management Discussion Report, Corporate Governance Report, and CEO's certification for the year ended March 31, 2026. Additionally, the appointment of Mrs. Vijaya Mani as a Director and Mr. N. K. Menon as Whole-time Director and CEO for a further term were approved, subject to member approval. The date for the 40th Annual General Meeting was finalized for September 22, 2026, with the Register of Members closing from September 15 to September 22, 2026. The company also appointed CA Ajay Ramsevak Sharma as Internal Auditor and M/s. Sanjay Dholakia & Associates as Secretarial Auditor for FY 2026-27.

Key Highlights

  • Board approved Un-Audited Financial Results for Q1 FY27.
  • Statutory auditors performed a limited review of the results.
  • Appointment of new Director and re-appointment of CEO approved.
  • 40th AGM scheduled for September 22, 2026.
  • Internal and Secretarial Auditors appointed for FY27.